rss

US strikes $2.1 billion coronavirus vaccine deal with Sanofi, GlaxoSmithKline

Sanofi, GSK selected for Operation Warp Speed

The deal will see the firms provide the US government with 100 million doses of the coronavirus vaccine, with the US to provide up to $2.1 billion for development, clinical trials, manufacturing and the delivery of the initial batch of doses.

The US will also have a further option for a supply of additional 500 million doses of the vaccine in the longer-term. GSK adds that if study data are postive, the companies can request US regulatory approval some time in 1H 2021.
To put a bit of a timeline on things, phase 1/2 of the study is expected to start in September with Phase 3 set to be conducted by the end of the year.
That’s another win for both firms after having struck a deal with the UK government earlier in the week here.

A history of Pfizer (1849 to 2015 )

Started in the 19th Century as a New York-based chemicals company, Pfizer has morphed into one of the titans of the healthcare industry. fastFT reviews the company’s history on the heels of its $150bn agreement to buy botox maker Allergan in the biggest-ever deal that will see it move its headquarters to Ireland.

1849:

Charles Pfizer and Charles Erhart, cousins, launch Charles Pfizer & Co. using $2,500 borrowed from Mr Pfizer’s father. The company’s first product was “a palatable form of santonin,” used to treat intestinal worms.

The company already grows roots in New York, utilising a warehouse in the Willamsburg portion of Brooklyn as an office, laboratory, factory and warehouse.

1880:

Pfizer begins making citric acid, and becomes the leading maker of the tart substance. Demand is boosted by new soft-drinks like Coca-Cola, Dr. Pepper and Pepsi-Cola.

1891:

Mr Erhart dies, and Mr Pfizer leverages an agreement that lets him consolidate ownership of the burgeoning company.

1900:

Pfizer incorporates in New Jersey. (more…)

Go to top